Enhancing Biologics with CESI-MS Characterization

May 18, 2020 | Biopharma, Blogs | 0 comments

Comprehensive characterization of a biologic requires analysis at both the intact and digest levels, but these analyses can be complex and cumbersome. For example, with conventional liquid chromatography separations, researchers are often left with limited information due to problems with either very small or very large protein and peptide retention. Unfortunately, slow going methods like these do not mesh with the rapid onset of novel drug approvals and researchers are left wanting more.  As in, a more reliable and comprehensive process for characterizing biologics to move them through the drug development pipeline, without compromising on results.Download the Latest Biologics Research >

Go with the CESI-MS Flow
The good news is there are alternatives to existing workflows. For example, using CESI coupled with mass spectrometers (CESI-MS), researchers gain a more comprehensive biologic outlook while at the same time saving almost a day’s worth of time in the lab. Intrigued? We’ve put together in an online eBook that provides vivid illustrations, application notes, and video demonstrations for a solid multi-level characterization biologic foundation, and it’s all here for the taking. This is not your typical brochure, but rather a self-guided tour to be shared with your co-workers as they ask questions and get immediate answers to their most pressing characterization questions. Discover ways to advance your biologics characterization studies using instrumentation like the CESI 8000 Plus coupled with a TripleTOF® mass spectrometer. Together, they give you high-resolution separations with the unique detection capabilities and dedicated software designed for biologics analysis.  From intact analysis to peptide mapping, get an inside look at how CESI-MS can advance your investigations of glycosylation, a drug to antibody ratio (DAR), disulfide bond mapping, and PTM identification. Go inside the lab and see the instrument at work using single injection technology for multi-level characterization of a biotherapeutic. Alternatively, view a video showing how powerful software solutions can help you to simplify your comparability work– all in this feature-rich online guide. It’s an interactive tour that gives you all the insight you need for linking CESI technology to high-performance mass spec.

 

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network